Cure My Disease

Don't miss your cure!

 Log in / Sign up

Brain cancer survivors team up with carers to tackle 'chemo brain'

NCT ID NCT05858359

Symptom relief Sponsor: Aarhus University Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a program called ImPACT for brain cancer survivors who have trouble with thinking and memory. The program pairs each survivor with a carer to identify strengths and challenges, and create practical strategies for daily life. The trial enrolled 27 survivors and their carers to see if the program is feasible and helpful.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
ImPACT program (behavioural intervention)
What this could lead to
If it works, this could offer a practical way for brain cancer survivors and their carers to manage thinking and memory problems at home.
What could go wrong
This is a small, early feasibility study with only 27 participants. Results may not apply to everyone, and the program may not improve cognitive function significantly.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

27 people

The number who actually took part.

Started

Jun 2023

Finished

Jun 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Diagnosis of brain cancer * Completed primary treatment at least 6 months ago * Medically stable * Speaks and understand Danish * Living with a carer aged 18 or over, who also speaks and understands Danish and consents to participate in the study alongside the patient Exclusion Criteria: • Confounding diagnosed or suspected psychiatric or medical condition unrelated to the cancer or its treatment

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Brain cancer are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

brain cancer Cognitive Dysfunction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Brain cancer Cognitive impairment

Contacts and locations

Locations

  • Aarhus University Hospital

    Aarhus, 8270, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.